Delivery Order SPE2DX22D0010-SPE2D824FLJ76
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $37,788.67, is for the supply of 40 milligram capsules of the pharmaceutical product Vyvanse. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vyvanse 40 mg capsules, a brand name pharmaceutical product, with a ceiling value of $1,054.38 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,564,026,397 units of the pharmaceutical product Vyvanse 70 mg capsule. The contract has a ceiling value of $1,776.83 and a performance period through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,662.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 100 units of Vyvanse 40 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,787,389 units of 40 mg Vyvanse capsules. The contract has a potential value of $2,038.25 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under a larger indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 30 mg Vyvanse capsules. The award has a ceiling value of $2,744.88 and a performance period through August 2024. This delivery order is placed against an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of Vyvanse 40 mg capsules to support military treatment programs and facilities. The award has a ceiling value of $2,413.41 and a performance period through March 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4,563,458,422 units of Vyvanse 50 mg capsules. The potential value of the award is $2,370.29, with a completion date of January 29, 2024. The contract has no set-aside designation. AmerisourceBergen Drug Corp is the prime...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,251,614 units of Vyvanse 10 mg capsules. The delivery order has a ceiling value of $12,387.82 and a period of performance through February 9, 2022. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. The delivery order is part of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,564,181,369 units of Vyvanse 40 mg capsules, a pharmaceutical product. The contract has a ceiling value of $7,913.79 and a performance period through April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no set-aside designations...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FLJ76Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 40mg Vyvanse capsules, a specialty pharmaceutical product, with a ceiling value of $31,568.87 and a performance period through April 4, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.6k | 4/3/24 |